ABSTRACT
Las hojas de eucalipto por muchos años se han empleado para aliviar las afecciones respiratorias; durante la pandemia su consumo se ha incrementado significativamente Objetivo. Determinar los efectos del consumo de eucalipto mediante diversas preparaciones caseras para el alivio de las afecciones respiratorias. Método. Se basa en la investigación descriptiva; pues se empleó cuestionario sobre que plantas se consumen para las afecciones respiratorias, con qué frecuencia se consume eucalipto y si el consumo de eucalipto alivia las afecciones respiratorias. Obtenidos los datos se procesaron con estadísticas básicas y análisis de correlación. Resultados. Se determinó que los pobladores encuestados utilizan plantas medicinales para el tratamiento de afecciones respiratorias, destacándose el uso de las hojas de eucalipto que consume el poblador con una frecuencia promedio de 2 veces por día de infusión de eucalipto. El porcentaje de alivio de los signos y síntomas de las afecciones respiratorias fue 80 %; la correlación del porcentaje de consumo de eucalipto con respecto al porcentaje de las personas que registraron alivio de sus afecciones respiratorias, alcanzó un valor de r= 0.989 y el análisis de varianza del porcentaje del consumo de eucalipto con relación al porcentaje que aliviaron las afecciones respiratorias, determinó un efecto significativo. Conclusión. Que el consumo de medicina natural a base de hojas de eucalipto se puede considerar como un tratamiento complementario y beneficioso para la salud; puesto que su composición tiene componentes activos tales como Cineol, α y ß-pineno, y limoneno, que tienen propiedades antibacterianas y antivirales.
Eucalyptus leaves have been used for many years to relieve respiratory conditions; during the pandemic its consumption has increased significantly Objective. To determine the effects of eucalyptus consumption through various home preparations for the relief of respiratory conditions. Method. It is based on descriptive research; since a questionnaire was used on which plants are consumed for respiratory conditions, how often eucalyptus is consumed and if the consumption of eucalyptus relieves respiratory conditions. Once the data was obtained, it was processed with basic statistics and correlation analysis. Results. It was determined that the surveyed residents use medicinal plants for the treatment of respiratory conditions, highlighting the use of eucalyptus leaves consumed by the population with an average frequency of 2 times per day of eucalyptus infusion. The percentage of relief of signs and symptoms of respiratory conditions was 80%; the correlation of the percentage of consumption of eucalyptus with respect to the percentage of people who reported relief from their respiratory conditions, reached a value of r= 0.989 and the analysis of variance of the percentage of consumption of eucalyptus with respect to the percentage that relieved respiratory conditions, determined a significant effect. Conclution. That the consumption of natural medicine based on eucalyptus leaves can be considered as a complementary and beneficial treatment for health; since its composition has active components such as Cineol, α and ß-pinene, and limonene, which have antibacterial and antiviral properties.
As folhas de eucalipto são usadas há muitos anos para aliviar problemas respiratórios; durante a pandemia seu consumo aumentou significativamente Objetivo. Determinar os efeitos do consumo de eucalipto através de diversas preparações caseiras para o alívio de problemas respiratórios. Método. Baseia-se em pesquisa descritiva; uma vez que foi aplicado um questionário sobre quais plantas são consumidas para condições respiratórias, com que frequência o eucalipto é consumido e se o consumo de eucalipto alivia as condições respiratórias. Uma vez obtidos os dados, estes foram processados com estatística básica e análise de correlação. Resultados. Constatou-se que os moradores pesquisados utilizam plantas medicinais para o tratamento de afecções respiratórias, destacando-se o uso de folhas de eucalipto consumidas pela população com frequência média de 2 vezes ao dia de infusão de eucalipto. O percentual de alívio dos sinais e sintomas de afecções respiratórias foi de 80%; a correlação do percentual de consumo de eucalipto com o percentual de pessoas que relataram alívio de suas condições respiratórias, atingiu um valor de r= 0,989 e a análise de variância do percentual de consumo de eucalipto com relação ao percentual que aliviou condições respiratórias, determinou um efeito significativo. Conclusão. Que o consumo de medicamentos naturais à base de folhas de eucalipto pode ser considerado um tratamento complementar e benéfico para a saúde; uma vez que sua composição possui componentes ativos como Cineol, α e ß-pineno e limoneno, que possuem propriedades antibacterianas e antivirais.
Subject(s)
Plants, Medicinal , Eucalyptus , Respiratory Tract Diseases , DiseaseABSTRACT
Aims: To determine if the ubiquitous herpes virus, cytomegalovirus (CMV), could be involved in a large and unexplained increase in all-cause mortality in England and Wales in 2012, and more specifically if this involvement was via a respiratory etiology. Study Design: Analysis of respiratory system cause of death in England and Wales and of respiratory system emergency hospital admissions in England. Place and Duration of Study: Cause of death statistics with primary respiratory system involvement in England and Wales in 2011 and 2012. Trends in emergency hospital admissions in England where there is a respiratory system primary diagnosis over the period 2000/01 to 2012/13. Methodology: Respiratory diagnoses which show a statistically significant increase as cause of death in 2012 were identified, as were diagnoses showing a statistically significant increase as the primary cause of an emergency hospital admission in 2012/13. These diagnoses were then compared with medical case studies for hospitalization and death due to CMV. Results: Deaths in England and Wales showed a sudden and unexplained increase in early 2012 which continued for 18 months before abating. The increase was equivalent to a large influenza epidemic, although higher levels attributable to influenza were absent. The increase was age and gender specific, and highest among those with neurodegenerative diseases (+15%); however, due to the way in which the primarycause of death is coded the role of respiratory diseases as the trigger for decease can be obscured. The next highest increase was for respiratory conditions, the most notable for bronchiectasis (+19%), asthma (female +14%), lung diseases due to external agents (+12%), interstitial pulmonary diseases (female +12%), chronic pulmonary disease (+7%) and a range of other conditions with >4% increases. After adjusting for the way in which deaths in the dementia group are coded the increase due to pneumonia rises to +8% for males and +15% for females. For the whole of the respiratory group augmented with the dementia group the increase in deaths was specific to those aged over 65 (average for 65+ of male +8.3%, female + 8.7%) with a peak at 90-94 (male + 15%, female + 17%). A corresponding large increase in respiratory admissions accompanies the increase in deaths. Given that the increase in admissions and deaths moved across England and Wales in a time-based spread, indicative of an infectious agent, with spurts of rapid local spread compatible with respiratory transmission, the increase in respiratory deaths were examined to see if the nature of any putative infectious agent could be discerned. There was a striking match with the known clinical effects of CMV. Conclusion: In an aged population lifelong exposure to the immune erosive effects of CMV presents the potential for the emergence of diseases reliant on immune impairment for their modus operandi. The lung is a primary reservoir for permanent CMV infection in humans and conditions/diagnoses showing a large increase in both death and hospital admissions in 2012 are all potentially CMV-mediated. In view of the very large increase in death for particular respiratory diagnoses further research is urgently required.
ABSTRACT
Los transportistas pueden constituir una población con características especiales: sedentarismo, tabaquismo y obesidad, que los predispone a numerosas enfermedades crónicas. Los objetivos de este trabajo fueron evaluar la prevalencia de compromiso respiratorio subdiagnosticado de tabaquismo y obesidad en transportistas de la Provincia de Córdoba. Material y métodos: Evaluación de 297 transportistas durante el examen médico para renovación de su licencia, en una clínica de la ciudad de Córdoba, a través de una encuesta anónima auto-administrada y espirometría. Resultados: La prevalencia de síntomas respiratorios fue de 81.1% y la de tabaquismo de 59.3%. El 46.1% fuma > 10 cigarrillos/día. De los sujetos con espirometría obstructiva, el 55.5% tiene historia de tabaquismo. La prevalencia de obesidad fue del 44.1% y de sobrepeso/obesidad 84.8%. No hubo correlación entre IMC aumentado y alteración espirométrica. El grupo de sobrepeso/obesidad tuvo mayor prevalencia de síntomas sugestivos de SAHOS ya sea en el análisis de síntomas individuales (ronquidos p = 0.0001, apneas p = 0.03 y somnolencia p = 0.05) como en forma conjunta (p = 0.016). Conclusiones: Se encontró patología obstructiva subdiagnosticada en el 10% de la población estudiada y un elevado porcentaje de sujetos con síntomas sugestivos de SAHOS. La prevalencia de tabaquismo fue doble de la media nacional y 30% superior a la media de la provincia de Córdoba. La prevalencia de obesidad fue 3 veces más elevada que la reportada en el país, con más del 80% de la muestra con IMC > 25 kg/m2.
Professional drivers may constitute a population with special features: sedentary lifestyle plus prevalence of smoking habit and obesity, which predispose them to several chronic diseases. The objectives of this study were to evaluate the prevalence of underdiagnosed respiratory conditions, smoking habit and obesity, among professional drivers of Cordoba province. Material and Methods: Evaluation of 297 professional drivers during the medical examination for driving license renewal, at a clinic in the city of Córdoba, through a self - administered anonymous questionnaire and spirometry. Results: The prevalence of respiratory symptoms was 81.1% and that of the smoking habit was 59.3%; 46.1% smoked >10 cigarettes/day. In the group of subjects with obstructive spirometry, 55.5% had a history of smoking. The prevalence of obesity was 44.1% and overweight/obesity 84.8%. There was no correlation between increased BMI and spirometric impairment. The group of overweight/obesity had a higher prevalence of symptoms suggestive of OSA, both in the analysis of individual symptoms (snoring p = 0.0001, apnea p = 0.03 and somnolence p = 0.05 ) and in the analysis of all the symptoms together (p = 0.016). Conclusions: Obstructive underdiagnosed pathology was found in 10% of the study population and in a high percentage of subjects with symptoms suggestive of OSA. Smoking habit prevalence was twice the national average and 30% higher than the average of the Cordoba province. The prevalence of obesity was 3 times higher than that reported in the country; over 80% of the sample had a BMI higher than 25 kg/m2.